Vitamin D and L-cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients

European Journal of Clinical Nutrition

Volumn 68, Issue 10, 2014, Pages 1148-1153

  Jain, S K ^a   Micinski, D ^a   Huning, L ^a   Kahlon, G ^b   Bass, P F ^b   Levine, S N ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYSTEINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEMOGLOBIN A1C; TRIACYLGLYCEROL; VITAMIN D; INSULIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY WEIGHT; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MONOCYTE CULTURE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; SUPPLEMENTATION; U937 CELL LINE; UPREGULATION; VITAMIN BLOOD LEVEL; BIOSYNTHESIS; BLOOD; CELL LINE; CLINICAL TRIAL; DIETARY SUPPLEMENT; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MONOCYTE; OXIDATIVE STRESS;

CELL LINE; CYSTEINE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MONOCYTES; OXIDATIVE STRESS; TRIGLYCERIDES; VITAMIN D;

EID: 84926178023     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.114     Document Type: Article

References (44)

1. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007; 113: 234-258
2. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-492
3. Newsholme P, Rebelato E, Abdulkader F, Krause M, Carpinelli A, Curi R., et al. Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids. J Endocrinol 2012; 214: 11-20
4. Newsholme P, Krause M. Nutritional regulation of insulin secretion: implications for diabetes. Clin Biochem Rev 2012; 33: 35-47
5. Rutten EP, Engelen MP, Schols AM, Deutz NE. Skeletal muscle glutamate metabolism in health and disease: state of the art. Curr Opin Clin Nutr Metab Care 2005; 8: 41-51
6. Sekhar RV, McKay SV, Patel SG. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011; 34: 162-167
7. Darmaun D, Smith SD, Sweeten S, Hartman BK, Welch C, Mauras N., et al. Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-Acetylcysteine supplementation. Pediatr Diabetes 2008; 9: 577-582
8. Jain SK, McVie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994; 43: 306-309
9. Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N., et al. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 2005; 54: 190-196
10. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-1015
11. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE., et al. The nonskeletal effects of vitamin D: an endocrine society scientific statement. Endocr Rev 2012; 33: 456-492
12. Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011; 65: 1016-1026
13. Jain SK, Kannan K, Lim G, McVie R, Bocchini JA. Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients and is apparently mediated by oxidative stress and cAMP-deficiency. Diabetes 2002; 51: 2287-2293
14. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 1999; 45: 290-292
15. Jain SK, Kahlon G, Morehead L, Lieblong B, Stapleton T, Hoeldtke R., et al. The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients. Metab Syndr Relat Disord 2012; 10: 331-336
16. Sokol RJ, Heubi JE, Iannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med 1984; 310: 1209-1212
17. Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ., et al. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects of Med 2009; 30: 86-98
18. Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U-937 monocytes. Biochem Biophys Res Commun 2013; 437: 7-11
19. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 1989; 264: 21340-21345
20. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539-1543
21. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011; 50: 567-575
22. Krause M, Rodrigues-Krause J, O'Hagan C, De Vito G, Boreham C, Susta D., et al. Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study. Metabolism 2012; 61: 1528-1537
23. Ji L, Jiang P, Lu B, Sheng Y, Wang X, Wang Z., et al. Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism. J Nutr Biochem 2013; 24: 1911-1919
24. Jain SK, Velusamy T, Croad JL, Rains JL, Bull R. L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, oxidative stress and inhibits NFkB activation in the livers of Zucker diabetic rats. Free Radic Biol Med 2009; 46: 1633-1638
25. Aune D, Norat T, Romundstad P, Vatten L. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-Analysis of cohort studies. Am J Clin Nutr 2013; 98: 1066-1083
26. Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG., et al. Effects of N-Acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 2006; 543: 151-157
27. Gaudel C, Nongonierma AB, Maher S, Flynn S, Krause M, Murray BA., et al. A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. J Nutr 2013; 143: 1109-1114
28. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ. Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. J Nutr 2011; 141: 582-587
29. Liu Z, Li J, Zeng Z, Liu M, Wang M. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chem Biol Interact 2008; 173: 68-75
30. Pieper GM, Siebeneich W. Oral administration of the antioxidant, N-Acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1998; 32: 101-105
31. Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A., et al. Long-term N-Acetylcysteine and L-Arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diab Care 2008; 31: 940-944
32. Ozkilic AC, Cengiz M, Ozaydin A, Cobanoglu A, Kanigur G. The role of N-Acetylcysteine treatment on anti-oxidative status in patients with type II diabetes mellitus. J Basic Clin Physiol Pharmacol 2006; 17: 245-254
33. Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G., et al. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clin Ther 2005; 27: 1764-1773
34. Gunnerud UJ, Ostman EM, Björck IM. Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose-response study. Eur J Clin Nutr 2013; 67: 749-753
35. Mortensen LS, Holmer-Jensen J, Hartvigsen ML, Jensen VK, Astrup A, de Vrese M., et al. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes. Eur J Clin Nutr 2012; 66: 799-805
36. Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial. Eur J Clin Nutr 2013; 67: 64-70
37. Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T., et al. Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res 2012; 56: 1333-1341
38. De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Armiento A, Ferri C., et al. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1998; 47: 993-997
39. Kim BS, Cha HN, Kim YW, Kim JY, Dan JM, Park SY., et al. Inhibition of lipid infusion-induced skeletal muscle insulin resistance by cotreatment with tempol and glutathione in mice. J Pharmacol Sci 2009; 110: 370-380
40. Guarino MP, Macedo MP. Co-Administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 2006; 147: 959-965
41. Nguyen D, Hsu JW, Jahoor F, Sekhar RV. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity and body composition in older HIV-infected patients. J Clin Endocrinol Metab 2014; 99: 169-177
42. Borges MC, Martini LA, Rogero MM. Current prospective on vitamin D, immune system, and chronic diseases. Nutrition 2011; 27: 399-404
43. Manna P, Jain SK. Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-γ-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem 2012; 287: 42324-42332
44. Jain SK, Manna P, Micinski D, Lieblong BJ, Kahlon G, Morehead L., et al. In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress?. Antioxid Redox Signal 2013; 18: 1154-1158